| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | narciclasine | CTRPv2 | pan-cancer | AAC | -0.091 | 0.01 |
| mRNA | triazolothiadiazine | CTRPv2 | pan-cancer | AAC | -0.082 | 0.01 |
| mRNA | I-BET151 | CTRPv2 | pan-cancer | AAC | -0.084 | 0.01 |
| mRNA | BRD-K96970199 | CTRPv2 | pan-cancer | AAC | 0.19 | 0.02 |
| mRNA | BI-2536 | CTRPv2 | pan-cancer | AAC | -0.083 | 0.02 |
| mRNA | CMK | GDSC1000 | pan-cancer | AAC | 0.13 | 0.02 |
| mRNA | Bortezomib | gCSI | pan-cancer | AAC | 0.2 | 0.02 |
| mRNA | SR-II-138A | CTRPv2 | pan-cancer | AAC | -0.081 | 0.02 |
| mRNA | ABT-263 | FIMM | pan-cancer | AAC | 0.35 | 0.02 |
| mRNA | temsirolimus | GDSC1000 | pan-cancer | AAC | -0.08 | 0.02 |